✦ LIBER ✦

Potent complementary clinical benefit of abciximab and stenting during percutaneous coronary revascularization in patients with diabetes mellitus: Results of the EPISTENT trial

✍ Scribed by A.Michael Lincoff

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Coronary Flow Reserve and

✍ Annapoorna S. Kini; Michael C. Kim; Pedro R. Moreno; Prakash Krishnan; Oana C. I 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 494 KB

Use of Bivalirudin During Percutaneous C

✍ Hitinder S. Gurm; Ian J. Sarembock; Dean J. Kereiakes; John J. Young; Robert A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Outcomes in Diabetic and Nondiabetic Pat

✍ Dean J. Kereiakes; Donald E. Cutlip; Robert J. Applegate; John Wang; Manejeh Yaq 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 349 KB

AS-208 The Impact of Potent Statin on Si

✍ Ji Young Park; Seung-Woon Rha; Kanhaiya L. Poddar; Meera Kumari; Byoung Geol Cho 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 531 KB